Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a novel beta coronavirus. SARS-CoV-2 uses spike glycoprotein to interact with host angiotensin-converting enzyme 2 (ACE2) and ensure cell recognition. High infectivity of SARS-CoV-2 rai...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Masaud, Ahmad, Bilal, Choi, Sangdun, Woo, Hyun Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657873/
https://www.ncbi.nlm.nih.gov/pubmed/33200028
http://dx.doi.org/10.1016/j.csbj.2020.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657873/
https://www.ncbi.nlm.nih.gov/pubmed/33200028
http://dx.doi.org/10.1016/j.csbj.2020.11.002

Ejemplares similares